Regulation, Compliance & Legal › Sub-category

Fraud / Investigation

5 articles
Allegations of financial misstatement and regulatory scrutiny are casting a shadow over Indian corporations. Sumitomo Pharma faces claims of ¥165 billion in revenue misreporting, triggering a share price decline and raising concerns about corporate governance, while Olympic Oil received a qualified auditor's opinion due to material uncertainties and loan defaults, potentially jeopardizing its going concern status. Simultaneously, Unifinz Capital is under investigation for cybercrime, and while maintaining normal operations, the situation underscores heightened regulatory oversight. These developments highlight increased investor caution regarding financial transparency and risk management within the sector.